|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ozenne V, Bouattour M, Goutté N, et al:
Prospective evaluation of the management of hepatocellular
carcinoma in the elderly. Dig Liver Dis. 43:1001–1005. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lau WY and Lai EC: Hepatocellular
carcinoma: current management and recent advances. Hepatobiliary
Pancreat Dis Int. 7:237–257. 2008.PubMed/NCBI
|
|
4
|
Hawkins MA and Dawson LA: Radiation
therapy for hepatocellular carcinoma from palliation to cure. Clin
Cancer Res. 106:1653–1661. 2006.PubMed/NCBI
|
|
5
|
Takayama T: Surgical treatment for
hepatocellular carcinoma. Jpn J Clin Oncol. 41:447–454. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cha CH, Saif MW, Yamane BH and Weber SM:
Hepatocellular carcinoma: current management. Curr Probl Surg.
47:10–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma S, Jiao B, Liu X, et al: Approach to
radiation therapy in hepatocellular carcinoma. Cancer Treat Rev.
36:157–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wertheim JA, Petrowsky H and Saab S: Major
challenges limiting liver transplantation in the United States. Am
J Transplant. 11:1773–1784. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wiggermann P, Jung EM and Stroszczynski C:
Radiofrequency ablation is a technique finished? Radiologe.
52:9–14. 2012.PubMed/NCBI
|
|
10
|
Liapi E and Geschwind JF: Medium-sized
HCC: achieving effective local tumor control with combined
chemoebolization and radiofrequency ablation. Ann Surg Oncol.
18:1527–1528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smerdou C, Menne S, Hernandez-Alcoceba R
and Gonzalez-Aseguinolaza G: Gene therapy for HCV/HBV-induced
hepatocellular carcinoma. Curr Opin Investig Drugs. 11:1368–1377.
2010.PubMed/NCBI
|
|
12
|
Truty MJ and Vauthey JN: Surgical
resection of high-risk hepatocellular carcinoma: patient selection,
preoperative considerations, and operative technique. Ann Surg
Oncol. 17:1219–1225. 2010. View Article : Google Scholar
|
|
13
|
Abelev GI, Perova SD, Khramkova NI,
Postnikova ZA and Irlin IS: Production of embryonal alpha-globulin
by transplantable mouse hepatomas. Transplantation. 1:174–180.
1963. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lok AS, Sterling RK, Everhart JE, et al:
Des-γ-carboxy prothrombin and α-fetoprotein as biomarkers for the
early detection of hepatocellular carcinoma. Gastroenterology.
138:493–502. 2010.
|
|
15
|
Giardina MG, Matarazzo M, Varriale A,
Morante R, Napoli A and Martino R: Serum alpha-L-fucosidase: a
useful marker in the diagnosis of hepatocellular carcinoma. Cancer.
70:1044–1048. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishizuka H, Nakayama T, Matsuoka S, et al:
Prediction of the development of hepato-cellular carcinoma in
patients with liver cirrhosis by the serial determinations of serum
alpha-L-fucosidase activity. Intern Med. 38:927–931. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu ZW, Friess H, Wang L, et al: Enhanced
glypican-3 expression differentiates the majority of hepatocellular
carcinomas from benign hepatic disorders. Gut. 48:558–564. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Allegretta M and Filmus J: Therapeutic
potential of targeting glypican-3 in hepatocellular carcinoma.
Anticancer Agents Med Chem. 11:543–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oka H, Tamori A, Kuroki T, Kobayashi K and
Yamamoto S: Prospective study of alpha-fetoprotein in cirrhotic
patients monitored for development of hepatocellular carcinoma.
Hepatology. 19:61–66. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ishii M, Gama H, Chida N, et al:
Simultaneous measurements of serum alpha-fetoprotein and protein
induced by vitamin K absence for detecting hepatocellular
carcinoma. Am J Gastroenterol. 95:1036–1040. 2000.
|
|
21
|
Marrero JA, Su GL, Wei W, Emick D,
Conjeevaram HS, Fontana RJ and Lok AS: Des-gamma carboxyprothrombin
can differentiate hepatocellular carcinoma from nonmalignant
chronic liver disease in American patients. Hepatology.
37:1114–1121. 2003. View Article : Google Scholar
|
|
22
|
Gambarin-Gelwan M, Wolf DC, Shapiro R,
Schwartz ME and Min AD: Sensitivity of commonly available screening
tests in detecting hepatocellular carcinoma in cirrhotic patients
undergoing liver transplantation. Am J Gastroenterol. 95:1535–1538.
2000. View Article : Google Scholar
|
|
23
|
Trevisani F, D’Intino PE, Morselli-Labate
AM, et al: Serum alpha-fetoprotein for diagnosis of hepatocellular
carcinoma in patients with chronic liver disease: influence of
HBsAg and anti-HCV status. J Hepatol. 34:570–575. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toyoda H, Kumada T, Kiriyama S, et al:
Prognostic significance of simultaneous measurement of three tumor
markers in patients with hepatocellular carcinoma. Clin
Gastroenterol Hepatol. 4:111–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakamura S, Nouso K, Sakaguchi K, et al:
Sensitivity and specificity of des-gamma-carboxy prothrombin for
diagnosis of patients with hepatocellular carcinomas varies
according to tumor size. Am J Gastroenterol. 101:2038–2043. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Uto H, Kanmura S, Takami Y and Tsubouchi
H: Clinical proteomics for liver disease: a promising approach for
discovery of novel biomarkers. Proteome Sci. 8:702010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sherman M: Alphafetoprotein: an obituary.
J Hepatol. 34:603–605. 2001. View Article : Google Scholar
|
|
28
|
Losada A and Hirano T: Dynamic molecular
linkers of the genome: the first decade of SMC proteins. Genes Dev.
19:1269–1287. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu KH, Patterson AP and Wang L: Selection
of potential markers for epithelial ovarian cancer with gene
expression arrays and recursive descent partition analysis. Clin
Cancer Res. 10:3291–3300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kulawiec M, Safina A, Desouki MM, Still I,
Matsui S, Bakin A and Singh KK: Tumorigenic transformation of human
breast epithelial cells induced by mitochondrial DNA depletion.
Cancer Biol Ther. 7:1732–1743. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li J, Zhang N, Song LB, et al: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Freeman L, Aragon-Alcaide L and Strunnikov
A: The condensin complex governs chromosome condensation and
mitotic transmission of rDNA. J Cell Biol1. 49:811–824. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu L, Peña Castillo L, Mnaimneh S, Hughes
TR and Brown GW: A survey of essential gene function in the yeast
cell division cycle. Mol Biol Cell1. 7:4736–4747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Klijn JG, Zhang Y, et al:
Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
